about
Vitamin D in a northern Canadian first nation population: dietary intake, serum concentrations and functional gene polymorphismsUrine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology.Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study.Quantitation of allograft fibrosis and chronic allograft nephropathy.Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypassProtocol biopsies in the management of renal allograft recipients.Long-term allograft surveillance: the role of protocol biopsies.Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohortProteomic characterization of serine hydrolase activity and composition in normal urine.Effect of time on dialysis and renal transplantation on endothelial function: a longitudinal analysis.Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort.The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the AmericasDeveloping a tool for noninvasive monitoring of renal allografts.Dietary intake of vitamin D in a northern Canadian Dené First Nation communityThe impact of immune gene polymorphisms in kidney and liver transplantation.The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.Acceptable mismatching at the class II epitope level: the Canadian experience.Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.Long-term medical outcomes among Aboriginal living kidney donors.Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms.Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential.Proteomic-based detection of urine proteins associated with acute renal allograft rejection.Antibodies beyond HLA.Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.Lifetime probabilities of needing an organ transplant versus donating an organ after death.The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.Detection of a single nucleotide polymorphism in the IL-6 promoter region of ancient nuclear DNA.Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis.Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function.Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations.National conference to assess antibody-mediated rejection in solid organ transplantation.Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis.
P50
Q27334966-3860CED0-605F-4EF0-B524-19BD3A979F3DQ33195947-308B040C-D27C-4AED-83E2-19980462C8EEQ33290675-27C06571-04E1-4925-A22D-ECA7332E9310Q33391839-033694B5-DBEF-4C4A-80F2-D36F0086B541Q33774364-5F72AE81-DAC3-4E92-9E8B-DC73EF3441B4Q34008322-1DF626EC-F3FD-4EDD-9ED6-B511369E3819Q34112342-A3D96BFD-679E-484F-8D84-BED91E6554A8Q34165730-F96EBC2D-292B-4965-A60A-B796FA79EABBQ34367177-B56F0B46-C56B-483D-94BD-33346BDC54F3Q34478594-D391519B-8D57-47EC-A15C-083009DCD0BAQ34624708-37D45049-48E5-43A8-BF7F-62441FD65873Q34826271-8F4E3F5B-D5B2-43A4-9A95-202009F644DAQ35591668-AA33F107-D702-4734-B088-ADE25A3D7AEAQ36641460-C0DFFE3A-C2AB-48DF-99B6-6AF46F0A11B8Q37117984-5003636A-6B77-49B8-915A-A7B1E504D641Q37332949-A996EC84-B061-4A2E-8691-044263E76F3AQ37644840-516B980C-7D81-4C0D-9DBE-456351865CBFQ37648959-0C18CC38-B17B-4EAA-95F9-B63E6062C22AQ37667779-155629F3-353E-4AFD-9E5E-5D5792802DABQ38224515-6592410B-5656-4708-B9F4-F7604A41F85FQ41360833-BAEF352C-FE92-4107-BFF8-55EFB8D0930EQ42872476-AFD28CD4-309C-45C7-8081-AD47EB15B820Q43012261-68BD279A-3493-4996-95DD-917E7CB91CBEQ43036310-642BB8EE-3FF7-4D7E-99C5-6EF993466168Q43236422-6F715CEC-A5AC-4AE1-B755-11D977C0F18AQ43241668-3F98630A-21E7-4E9E-8260-1E457EAD4D07Q43611038-3E51DA94-1EF4-49B8-90D6-EAA4A9C8C03EQ43865301-32337A77-CB36-4051-A022-C94EABF388F2Q44008607-79710463-DCDC-4793-AFC5-354EFE15F0DFQ44193041-A77B8F4D-C148-4C38-A291-725E71840E43Q44539365-2EEA369D-D88C-429A-A4AC-9F7514D08C52Q44589298-B2DA7813-278A-4F76-86C3-FA803A0C4192Q44681433-7FB1946C-BC76-411A-B464-86BF9A96A580Q45627897-A79CE860-2FC0-4B91-A609-0FFD5DB849B3Q46038626-39B5026B-7CB2-464F-A654-21B8BE759A7FQ46422295-0919AF3D-C82B-4B82-90F7-12CAD8C9E3FBQ46908569-4E0E5B22-5D72-40A7-9A5A-96D0171E8FF4Q47295580-D20CB646-A626-426B-B131-FA8B6F1B5495Q47347260-4BD59D30-3B8A-4E47-80FE-F7F23B6A260BQ47751862-CA9709BC-3D3D-4E14-9D15-7ECD1E7E52A0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Nickerson
@ast
Peter Nickerson
@en
Peter Nickerson
@es
Peter Nickerson
@nl
Peter Nickerson
@sl
type
label
Peter Nickerson
@ast
Peter Nickerson
@en
Peter Nickerson
@es
Peter Nickerson
@nl
Peter Nickerson
@sl
prefLabel
Peter Nickerson
@ast
Peter Nickerson
@en
Peter Nickerson
@es
Peter Nickerson
@nl
Peter Nickerson
@sl
P106
P1153
7005395428
P21
P31
P496
0000-0002-7393-7799